Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-25 | RA Capital Management, L.P.Unternehmen | 32,88k | 292,13k | Kauf | 8,88 - 8,98 | 17,96M | 0,18% |
| 2026-06-12 | RA Capital Management, L.P.Unternehmen | 531,33k | 4,60M | Kauf | 8,57 - 8,99 | 17,92M | 3,06% |
| 2026-06-09 | RA Capital Management, L.P.Unternehmen | 1,43M | 11,14M | Kauf | 6,91 - 8,99 | 68,32k | -105,00% |
| 2026-06-09 | RA Capital Management, L.P.Unternehmen | 1,03M | 7,65M | Kauf | 6,91 - 7,91 | 17,39M | 6,28% |
| 2026-05-11 | GC Cell CorporationUnternehmen | 1,43M | 16,50M | Kauf | 11,52 | 6,00M | 31,36% |
| 2026-05-19 | Dr. Heather RaymonSVP of Research & Early Development | -3,10k | 27,88k | Verkauf | 9,01 | 148,23k | -2,05% |
| 2026-05-19 | Mr. Christopher P. HoranChief Technical Operations Officer | -7,00k | 63,07k | Verkauf | 9,01 | 293,45k | -2,33% |
| 2026-05-19 | Ms. Jennifer Kinsbruner BushCOO | -8,79k | 79,18k | Verkauf | 9,01 | 20,97k | -29,54% |
| 2026-05-19 | Dr. Subhashis BanerjeeChief Medical Officer | -7,04k | 63,39k | Verkauf | 9,01 | 144,96k | -4,63% |
| 2026-05-19 | Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director | -27,12k | 244,25k | Verkauf | 9,01 | 1,54M | -1,74% |
| 2026-05-11 | RA Capital Management, L.P.Unternehmen | 6,51M | 75,00M | Kauf | 11,52 | 15,20M | 74,89% |
| 2026-05-11 | RA Capital Management, L.P.Unternehmen | 2,17M | 0,00 | Open Market Derivative Acquisition | 0,00 | 2,17M | - |
| 2026-05-11 | RA Capital Management, L.P.Unternehmen | 6,51M | 75,00M | Kauf | 11,52 | 68,32k | -101,06% |
| 2026-02-15 | Dr. Heather RaymonSVP of Research & Early Development | -1,52k | 6,08k | Sale to Issuer | 4,00 | 151,32k | -1,00% |
| 2026-02-15 | Mr. Christopher P. HoranChief Technical Operations Officer | -2,19k | 8,75k | Sale to Issuer | 4,00 | 300,45k | -0,72% |
| 2026-02-15 | Ms. Jennifer Kinsbruner BushCOO | -3,52k | 14,06k | Sale to Issuer | 4,00 | 26,63k | -11,66% |
| 2026-02-15 | Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director | -14,60k | 58,40k | Sale to Issuer | 4,00 | 1,56M | -0,93% |
| 2025-12-15 | Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director | -3,19k | 19,12k | Automatic Disposition | 6,00 | 1,21M | -0,26% |
| 2025-11-15 | Mr. Christopher P. HoranChief Technical Operations Officer | -1,90k | 6,17k | Sale to Issuer | 3,25 | 78,18k | -2,37% |
| 2025-11-15 | Dr. Heather RaymonSVP of Research & Early Development | -1,38k | 4,47k | Sale to Issuer | 3,25 | 39,59k | -3,36% |
| 2025-11-15 | Ms. Jennifer Kinsbruner BushCOO | -3,06k | 9,93k | Sale to Issuer | 3,25 | 18,84k | -13,95% |
| 2025-11-17 | Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director | -6,38k | 21,52k | Automatic Disposition | 3,38 | 344,00k | -1,82% |
| 2025-11-15 | Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director | -6,35k | 20,63k | Sale to Issuer | 3,25 | 344,00k | -1,81% |
| 2025-11-15 | Ms. Neha KrishnamohanInsider | -3,49k | 11,34k | Sale to Issuer | 3,25 | 19,36k | -15,28% |
| 2025-10-17 | Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director | -25,50k | 153,00k | Automatic Disposition | 6,00 | 356,72k | -6,67% |
| 2025-05-15 | Mr. Christopher P. HoranChief Technical Operations Officer | -4,92k | 12,69k | Sale to Issuer | 2,13 - 2,75 | 80,08k | -5,79% |
| 2025-05-15 | Ms. Neha KrishnamohanInsider | -7,15k | 18,84k | Sale to Issuer | 2,13 - 2,75 | 15,97k | -30,94% |
| 2025-05-15 | Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director | -8,94k | 21,82k | Sale to Issuer | 2,13 - 2,75 | 382,22k | -2,29% |
| 2025-05-15 | Dr. Heather RaymonSVP of Research & Early Development | -2,38k | 6,09k | Sale to Issuer | 2,13 - 2,75 | 40,97k | -5,50% |
| 2025-08-15 | Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director | -25,50k | 69,58k | Automatic Disposition | 2,73 | 382,22k | -6,25% |
| 2025-05-15 | Ms. Jennifer Kinsbruner BushCOO | -8,35k | 21,75k | Sale to Issuer | 2,13 - 2,75 | 14,45k | -36,61% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
